blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2350266

EP2350266 - METHOD FOR TREATING OR PREVENTING A PANCREATIC DYSFUNCTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.06.2016
Database last updated on 17.07.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Mesoblast, Inc.
505 Fifth Avenue
Third Floor
New York, NY 10017 / US
[2015/50]
Former [2012/21]For all designated states
Mesoblast, Inc.
275 Madison Avenue 4th Floor
New York NY 10016 / US
Former [2011/31]For all designated states
Angioblast Systems, Inc.
275 Madison Avenue 4th Floor
New York, New York 10016 / US
Inventor(s)01 / ITESCU, Silviu
Level 39, 55 Collins Street
Melbourne Victoria 3000 / AU
02 / KRISHNAN, Ravi
63 Battams Road
Royston Park South Australia 5070 / AU
 [2011/31]
Representative(s)Lee, Nicholas John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2015/31]Lee, Nicholas John, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Former [2011/31]Lee, Nicholas John, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date09827049.919.11.2009
[2011/31]
WO2009AU01511
Priority number, dateUS20080199796P20.11.2008         Original published format: US 199796 P
[2011/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010057260
Date:27.05.2010
Language:EN
[2010/21]
Type: A1 Application with search report 
No.:EP2350266
Date:03.08.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2010 takes the place of the publication of the European patent application.
[2011/31]
Type: B1 Patent specification 
No.:EP2350266
Date:29.07.2015
Language:EN
[2015/31]
Search report(s)International search report - published on:AU27.05.2010
(Supplementary) European search report - dispatched on:EP31.01.2013
ClassificationIPC:C12N5/077, A61P1/18, A61P5/48, A61K35/12, A61K35/39, C12N5/02
[2011/31]
CPC:
A61K35/12 (EP,KR,US); A61K35/545 (US); A61K35/39 (KR);
A61K45/06 (KR,US); A61K9/0019 (KR); A61P1/18 (EP);
A61P13/12 (EP); A61P3/00 (EP); A61P3/08 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P37/02 (EP);
A61P43/00 (EP); A61P5/48 (EP); A61P5/50 (EP);
C12N5/0676 (EP,KR,US); G01N33/66 (US); G01N33/6893 (US);
G01N33/74 (US); G01N2333/47 (US); G01N2333/62 (US);
G01N2800/042 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/31]
Former [2011/31]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR BEHANDLUNG ODER VERHINDERUNG EINER PANKREAS-DYSFUNKTION[2011/31]
English:METHOD FOR TREATING OR PREVENTING A PANCREATIC DYSFUNCTION[2011/31]
French:PROCÉDÉ POUR TRAITER OU PRÉVENIR UN DYSFONCTIONNEMENT PANCRÉATIQUE[2011/31]
Entry into regional phase19.05.2011National basic fee paid 
19.05.2011Search fee paid 
19.05.2011Designation fee(s) paid 
19.05.2011Examination fee paid 
Examination procedure19.05.2011Examination requested  [2011/31]
22.08.2013Amendment by applicant (claims and/or description)
20.09.2013Despatch of a communication from the examining division (Time limit: M06)
20.03.2014Reply to a communication from the examining division
26.11.2014Despatch of a communication from the examining division (Time limit: M04)
05.12.2014Reply to a communication from the examining division
11.03.2015Communication of intention to grant the patent
17.06.2015Fee for grant paid
17.06.2015Fee for publishing/printing paid
17.06.2015Receipt of the translation of the claim(s)
Divisional application(s)EP15178550.8  / EP3002329
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.09.2013
Opposition(s)02.05.2016No opposition filed within time limit [2016/27]
Fees paidRenewal fee
20.09.2011Renewal fee patent year 03
13.11.2012Renewal fee patent year 04
18.11.2013Renewal fee patent year 05
10.11.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.11.2009
AT29.07.2015
BG29.07.2015
CY29.07.2015
CZ29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
MK29.07.2015
MT29.07.2015
PL29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
SM29.07.2015
TR29.07.2015
NO29.10.2015
GR30.10.2015
LU19.11.2015
IS29.11.2015
PT30.11.2015
[2018/30]
Former [2017/38]HU19.11.2009
AT29.07.2015
BG29.07.2015
CY29.07.2015
CZ29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
MT29.07.2015
PL29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
SM29.07.2015
TR29.07.2015
NO29.10.2015
GR30.10.2015
LU19.11.2015
IS29.11.2015
PT30.11.2015
Former [2016/36]AT29.07.2015
CZ29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
PL29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
NO29.10.2015
GR30.10.2015
LU19.11.2015
IS29.11.2015
PT30.11.2015
Former [2016/31]AT29.07.2015
CZ29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
PL29.07.2015
RO29.07.2015
SE29.07.2015
SK29.07.2015
NO29.10.2015
GR30.10.2015
LU19.11.2015
IS29.11.2015
PT30.11.2015
Former [2016/28]AT29.07.2015
CZ29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
PL29.07.2015
RO29.07.2015
SE29.07.2015
SK29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/23]AT29.07.2015
CZ29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
PL29.07.2015
RO29.07.2015
SE29.07.2015
SK29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/22]AT29.07.2015
CZ29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
PL29.07.2015
SE29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/11]AT29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
PL29.07.2015
SE29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/10]FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
PL29.07.2015
SE29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/09]FI29.07.2015
LT29.07.2015
LV29.07.2015
NO29.10.2015
GR30.10.2015
Former [2016/08]LT29.07.2015
NO29.10.2015
Former [2016/07]LT29.07.2015
Documents cited:Search[I]WO2004016747  (UNIV FLORIDA [US]) [I] 1-14 * the whole document *;
 [I]WO2007127408  (TULANE UNIVERSITY HEALTH SCIEN [US], et al) [I] 1-14 * figure 1; example 1 *;
 [I]  - EZQUER F E ET AL, "Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice", BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, KLUGE CARDEN JENNINGS PUBLISHING, CHARLOTTESVILLE, VA, US, vol. 14, no. 6, doi:10.1016/J.BBMT.2008.01.006, ISSN 1083-8791, (20080601), pages 631 - 640, (20080414), XP022668419 [I] 1-14 * figure 4 *

DOI:   http://dx.doi.org/10.1016/j.bbmt.2008.01.006
 [I]  - TIMPER K ET AL, "Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 341, no. 4, doi:10.1016/J.BBRC.2006.01.072, ISSN 0006-291X, (20060324), pages 1135 - 1140, (20060324), XP024923809 [I] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2006.01.072
 [I]  - LEE RYANG HWA ET AL, "Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20061101), vol. 103, no. 46, doi:10.1073/PNAS.0608249103, ISSN 0027-8424, pages 17438 - 17443, XP002459835 [I] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.0608249103
 [A]  - STAN GRONTHOS ET AL, A Method to Isolate and Purify Human Bone Marrow Stromal Stem Cells, MESENCHYMAL STEM CELLS : METHODS AND PROTOCOLS; [METHODS IN MOLECULAR BIOLOGY], TOTOWA, NJ : HUMANA PRESS, US, PAGE(S) 45 - 57, (20080401), ISBN 978-1-58829-771-6, XP008144677 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1007/978-1-60327-169-1_3
International search[X]WO2006032092  (ANGIOBLAST SYSTEMS INC [US], et al);
 [Y]  - EZQUER, F. E. ET AL., "Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice", BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION., (200806), vol. 14, no. 6, pages 631 - 640, XP022668419

DOI:   http://dx.doi.org/10.1016/j.bbmt.2008.01.006
 [Y]  - LEE, R. H. ET AL., "'Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE OF THE UNITED STATES OF AMERICA., (2006), vol. 103, no. 46, pages 17438 - 17443, XP002459835

DOI:   http://dx.doi.org/10.1073/pnas.0608249103
 [Y]  - OH, S-H. ET AL., "Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes", LABORATORY INVESTIGATION., (2004), vol. 84, pages 607 - 617, XP008146969

DOI:   http://dx.doi.org/10.1038/labinvest.3700074
 [Y]  - GRONTHOS, S. ET AL., "'Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow", JOURNAL OF CELL SCIENCE., (2003), vol. 116, pages 1827 - 1835, XP009083626

DOI:   http://dx.doi.org/10.1242/jcs.00369
 [Y]  - KOLF, C. M. ET AL., "Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation", ARTHRITIS RESEARCH & THERAPY., (2007), vol. 9, no. 1, pages 204 - 211, XP008146968

DOI:   http://dx.doi.org/10.1186/ar2116
 [A]  - LIU, M. ET AL., "Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE., (200808), vol. 12, no. 4, pages 1155 - 1168, XP002541175

DOI:   http://dx.doi.org/10.1111/j.1582-4934.2008.00288.x
by applicantWO9201070
 US5139941
 US5173414
 WO9303769
 WO0104268
 WO0114268
 WO2004085630
 WO2006032092
    - BABU ET AL., MOL ENDOCRINOL., (2006), vol. 20, pages 3133 - 3145
    - BUTEAU, DIABETES AND METABOLISM, (2008), vol. 34, pages S73 - S77
    - SHAPIRO ET AL., NEW ENG. J. MED., (2000), vol. 343, pages 230 - 238
    - BURNS ET AL., J. ENDOCRINOLOGY, (2004), vol. 103, pages 437 - 443
    - KAHN ET AL., AM. J. MED., (2000), vol. 108, pages 2S - 8S
    - SAMBROOK; FRITSCH; MANIATIS, Molecular Cloning: A Laboratory Manual, COLD SPRING HARBOR LABORATORIES, (1989), vol. I, II
    - DNA Cloning: A Practical Approach, IRL PRESS, (1985), vol. I, II
    - J.F. RAMALHO ORTIGAO, "The Chemistry of Peptide Synthesis", KNOWLEDGE DATABASE OF ACCESS TO VIRTUAL LABORATORY WEBSITE (INTERACTIVA, GERMANY
    - SAKAKIBARA, D.; TEICHMAN, J.; LIEN, E.; FENICHEL, R.L., BIOCHEM. BIOPHYS. RES. COMMUN., (1976), vol. 73, pages 336 - 342
    - MERRIFIELD, R.B., J. AM. CHEM. SOC., (1963), vol. 85, pages 2149 - 2154
    - BARANY, G.; MERRIFIELD, R.B., The Peptides, ACADEMIC PRESS, (1979), vol. 2, pages 1 - 284
    - Synthese von Peptiden in Houben-Weyls Metoden der Organischen Chemie, THIEME, (1974), vol. 15
    - BODANSZKY, M., INT. J. PEPTIDE PROTEIN RES., (1985), vol. 25, pages 449 - 474
    - Handbook of Experimental Immunology, BLACKWELL SCIENTIFIC PUBLICATIONS, (1986), vol. I-IV
    - GRONTHOS ET AL., BLOOD, (1995), vol. 85, pages 929 - 940
    - BUCHSCHER ET AL., J VIROL., (1992), vol. 56, pages 2731 - 2739
    - JOHANN ET AL., J. VIROL., (1992), vol. 65, pages 1635 - 1640
    - SOMMERFELT ET AL., VIROL., (1990), vol. 76, pages 58 - 59
    - WILSON ET AL., J. VIROL., (1989), vol. 63, pages 274 - 2318
    - MILLER ET AL., J. VIROL., (1991), vol. 65, pages 2220 - 2224
    - MILLER; ROSMAN, BIOTECHNIQUES, (1989), vol. 7, pages 980 - 990
    - MILLER, A. D, HUMAN GENE THERAPY, (1990), vol. 7, pages 5 - 14
    - SCARPA ET AL., VIROLOGY, (1991), vol. 75, pages 849 - 852
    - BURNS ET AL., PROC. NATL. ACAD. SCI USA, (1993), vol. 90, pages 8033 - 8037
    - LEBKOWSKI ET AL., MOLEC. CELL. BIOL., (1988), vol. 5, pages 3988 - 3996
    - VINCENT ET AL., Vaccines, COLD SPRING HARBOR LABORATORY PRESS, (1990), page 90
    - CARTER, CURRENT OPINION IN BIOTECHNOLOGY, (1992), vol. 5, pages 533 - 539
    - MUZYCZKA, CURRENT TOPICS IN MICROBIOL, AND IMMUNOL., (1992), vol. 158, pages 97 - 129
    - KOTIN, HUMAN GENE THERAPY, (1994), vol. 5, pages 793 - 801
    - SHELLING; SMITH, GENE THERAPY, (1994), vol. 7, pages 165 - 169
    - ZHOU ET AL., J EXP. MED., (1994), vol. 179, pages 1867 - 1875
    - FISHER-HOCH ET AL., PROC. NATL ACAD. SCI. USA, (1989), vol. 56, pages 317 - 321
    - LÚKIC ET AL., DEVELOPMENTAL IMMUNOL., (1998), vol. 6, pages 119 - 128
    - ARULMOZHI ET AL., INDIAN J. PHARMACOL., (2004), vol. 36, pages 217 - 221
    - REES; ALCOLADO, DIABET. MED., (2005), vol. 22, pages 359 - 70
    - CARAWAY, AM. J. CLIN. PATHOL., (1959), vol. 32, pages 97 - 99
    - RINDERKNECHT; MARBACH, CLIN. CHEM. ACTA, (1972), vol. 29, pages 107 - 110
    - CONNON ET AL., DIGESTIVE DISEASES AND SCIENCES, (1978), vol. 23, pages 472 - 475
    - VACANTI ET AL., J. PED. SURG., (1988), vol. 23, pages 3 - 9
    - CIMA ET AL., BIOTECHNOL. BIOENG., (1991), vol. 38, page 145
    - VACANTI ET AL., PLAST. RECONSTR. SURG., (1991), vol. 88, pages 753 - 9
    - BOTTAZZO ET AL., LANCET, (1974), vol. 2, pages 1279 - 83
    - BROOKING ET AL., CLIN CHIM ACTA, (2003), vol. 331, pages 55 - 59
    - NAGATA ET AL., ANN. NEW YORK ACAD. SCI, (2004), vol. 1037, pages 10 - 15
    - GRONTHOS; ZANNETINO, METHODS MOL BIOL., (2008), vol. 449, pages 45 - 57
    - ZHOU ET AL., NATURE, (2008), vol. 455, pages 627 - 632
    - LIU ET AL., MOL THER, (2007), vol. 15, pages 86 - 93
    - WANG ET AL., DIABETES, (1998), vol. 47, pages 50 - 6
    - KIM ET AL., DIABETES, (2001), vol. 50, pages 1562 - 1570
    - MU ET AL., DIABETES, (2006), vol. 55, pages 1695 - 1704
    - TOURRELL ET AL., DIABETES, (2001), vol. 50, pages 1562 - 1570
    - LI ET AL., J BIOL CHEM, (2003), vol. 278, pages 471 - 478
    - GEZGINCI-OKTAYOGLU; BOLKENT, BIOCHEM CELL BIOL, (2009), vol. 87, pages 641 - 651
 WO1994US05700
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.